Radiation treatment for patients with intermediate-risk prostate cancer
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men wi...
Main Authors: | David E. Greene, Jyoti S. Mayadev, Richard K. Valicenti |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-06-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287212442977 |
Similar Items
-
Prostate cancer : image-guided radiation therapy /
by: Valicenti, Richard K., et al.
Published: (2008) -
Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer
by: Najlaa Alyamani, et al.
Published: (2021-06-01) -
166 Radiation Therapy and IRreversible Electroporation (RTIRE) for Intermediate Risk Prostate Cancer
by: Timothy McClure, et al.
Published: (2024-04-01) -
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
by: Ju Andrew W, et al.
Published: (2013-01-01) -
Stereotactic body radiation therapy for low- and low-intermediate risk prostate cancer: Is there a dose effect?
by: Alan Jay Katz, et al.
Published: (2011-12-01)